AnnElizabethDahlbergMD
Pediatric Hematology & Oncology • Seattle, WAInstructor, Pediatrics, University of Washington School of Medicine
Are you Dr. Dahlberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 42 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1959 NE Pacific St
C212 Box 356340
Seattle, WA 98195Phone+1 206-543-0065Fax+1 206-606-1025- Is this information wrong?
Summary
- Dr. Ann Dahlberg, MD is a pediatric hematologist/oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington, Idaho, and Alaska. She is affiliated with Seattle Children's Hospital and Fred Hutchinson Cancer Center.
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 2008 - 2011- University of WashingtonResidency, Pediatrics, 2005 - 2008
Harvard Medical SchoolClass of 2005
Certifications & Licensure
WA State Medical License 2008 - 2025
MT State Medical License 2021 - 2025
ID State Medical License 2021 - 2024
AK State Medical License 2021 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
Publications & Presentations
PubMed
- Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipients.Paolo Lopedote, Elisabetta Xue, Emily C Pao, Chiara Wychera, Ann E Dahlberg, Laurel Thur, Laura Roberts, Kelsey Baker, Ted A Gooley, Sangeeta Hingorani, Filippo Milano...> ;Frontiers in Oncology. 2023 Jan 1
- 33 citationsNaive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease.Marie Bleakley, Alison Sehgal, Stuart Seropian, Melinda A Biernacki, Elizabeth F Krakow, Ann Dahlberg, Heather Persinger, Barbara Hilzinger, Paul J Martin, Paul A Carp...> ;Journal of Clinical Oncology. 2022 Apr 10
- 26 citationsHematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage.Corinne Summers, Qian Vicky Wu, Colleen Annesley, Marie Bleakley, Ann Dahlberg, Prabha Narayanaswamy, Wenjun Huang, Jenna M. Voutsinas, Adam Brand, Wendy M. Leisenring...> ;Transplantation and Cellular Therapy. 2021 Oct 10
- Join now to see all
Press Mentions
Seattle Cancer Care Alliance to Present New Research at 62nd Annual Meeting of the American Society of HematologyDecember 4th, 2020
Hospital Affiliations
Seattle Children's HospitalSeattle, Washington
Fred Hutchinson Cancer CenterSeattle, Washington
